Gisela Velez, M.D., LLC
Gisela Velez, M.D., LLC was paid $327K by Medicaid between Jan 2018 and Oct 2024, across 13 billing codes. Its largest line is J2778, Injection, ranibizumab, 0.1 mg — 29% of everything it billed.
33Billing provider infoGISELA VELEZ, M.D., LLC
AYER, MA 01432
AYER, MA 01432
33aNPI1962767541assigned 07/10/2012
33bProvider typeSpecialist
28Total paid$327K
24GClaims8,037
24DCodes billed13
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Specialist providers in Massachusetts
Rank by total paid#36 of 179
Median peer was paid$23K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,812 | $54K | |
| 2019 | 2,126 | $96K | |
| 2020 | 1,318 | $67K | |
| 2021 | 1,236 | $76K | |
| 2022 | 698 | $19K | |
| 2023 | 521 | $8K | |
| 2024incomplete | 326 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | 29% | 354 | 271 | $95K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 17% | 1,071 | 867 | $56K |
| 92242 | 17% | 712 | 602 | $54K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 9.7% | 1,378 | 1,063 | $32K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.0% | 629 | 503 | $20K |
| 92134 | 4.9% | 1,335 | 935 | $16K | |
| 92250 | 4.9% | 601 | 594 | $16K | |
| 92273 | 3.3% | 273 | 257 | $11K | |
| 92226 | 2.6% | 843 | 638 | $8K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2.5% | 322 | 248 | $8K |
| 92235 | 2.0% | 156 | 125 | $7K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.2% | 115 | 80 | $4K |
1 more codes
| 92202 | <1% | 248 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialV ELEZ, GISELA (PRESIDENT)